title: Re: "Posterior reversible encephalopathy syndrome following infliximab infusion".
authors.forename: Veena
authors.initials: V
authors.lastname: Zamvar
authors.forename: John W
authors.initials: JW
authors.lastname: Puntis
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D000069285:Infliximab; D020258:Neurotoxicity Syndromes / Q000209:etiology*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab